Upstream Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Upstream Bio, Inc. (UPB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Current Assets
Cash and Cash Equivalents325.8925.8317.05
Short-Term Investments144.5683.980.00
Cash & Short-Term Investments470.45109.8117.05
Accounts Receivable1.180.240.41
Inventory0.000.000.00
Other Current Assets0.850.020.09
Total Current Assets479.16117.0018.31
Non-Current Assets
Property, Plant & Equipment (Net)2.370.200.16
Other Non-Current Assets0.190.000.01
Total Non-Current Assets2.560.200.17
Total Assets481.72117.2018.48
Current Liabilities
Accounts Payable4.041.990.71
Short-Term Debt1.410.000.00
Accrued Liabilities5.994.484.06
Other Current Liabilities5.290.000.00
Total Current Liabilities10.746.524.86
Non-Current Liabilities
Long-Term Debt1.130.000.01
Other Non-Current Liabilities0.002.876.95
Total Non-Current Liabilities1.13233.81119.78
Total Liabilities11.879.3911.81
Stockholders' Equity
Common Stock0.050.000.00
Retained Earnings-190.78-127.97-107.44
Accumulated Other Comprehensive Income-0.030.020.00
Additional Paid-in Capital660.604.821.28
Shares Outstanding53.6051.3451.34
Total Stockholders' Equity469.85107.816.67
Total Liabilities & Equity481.72117.2018.48